Get the Stockscreener App
17.24
0.70%
0.12
After Hours:
17.24
Phreesia Inc stock is traded at $17.24, with a volume of 1.42M.
It is up +0.70% in the last 24 hours and down -15.03% over the past month.
Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys.
See More
Previous Close:
$17.12
Open:
$17.11
24h Volume:
1.42M
Relative Volume:
1.33
Market Cap:
$1.04B
Revenue:
$434.53M
Net Income/Loss:
$-42.72M
P/E Ratio:
-23.30
EPS:
-0.74
Net Cash Flow:
$21.88M
1W Performance:
+1.23%
1M Performance:
-15.03%
6M Performance:
-40.53%
1Y Performance:
-35.07%
1-Day Range:
$17.08
$17.58
1-Week Range:
$16.24
$17.58
52-Week Range:
$15.41
$32.76
Phreesia Inc Stock (PHR) Company Profile
Name
Phreesia Inc
Sector
Industry
Phone
888-654-7473
Address
1521 CONCORD PIKE, WILMINGTON
Compare PHR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PHR
Phreesia Inc
|
17.24 | 1.03B | 434.53M | -42.72M | 21.88M | -0.74 |
|
VEEV
Veeva Systems Inc
|
237.87 | 36.38B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
69.54 | 11.51B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
45.69 | 8.60B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
95.45 | 7.99B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
40.67 | 7.08B | 11.99B | 24.18M | 234.31M | 0.2956 |
Phreesia Inc Stock (PHR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-13-25 | Initiated | BMO Capital Markets | Outperform |
| Sep-05-25 | Resumed | DA Davidson | Buy |
| Aug-27-25 | Initiated | Mizuho | Outperform |
| Jan-08-25 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Feb-26-24 | Initiated | Truist | Buy |
| Jan-17-24 | Upgrade | DA Davidson | Neutral → Buy |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Jan-04-23 | Reiterated | Needham | Buy |
| Dec-13-22 | Upgrade | Citigroup | Neutral → Buy |
| Dec-09-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Oct-13-22 | Initiated | DA Davidson | Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Jan-06-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Sep-02-21 | Reiterated | Needham | Buy |
| Aug-27-21 | Initiated | Canaccord Genuity | Buy |
| Jul-13-21 | Initiated | JMP Securities | Mkt Outperform |
| Jun-08-21 | Initiated | Berenberg | Buy |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Apr-01-21 | Initiated | Robert W. Baird | Outperform |
| Nov-11-20 | Initiated | Stephens | Overweight |
| Oct-27-20 | Initiated | Needham | Buy |
| Sep-22-20 | Initiated | DA Davidson | Buy |
| Jul-14-20 | Initiated | Citigroup | Neutral |
| May-15-20 | Initiated | Guggenheim | Buy |
| Apr-21-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Jan-31-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Jan-09-20 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-20-19 | Initiated | Raymond James | Outperform |
| Oct-11-19 | Initiated | Robert W. Baird | Outperform |
| Aug-13-19 | Initiated | JP Morgan | Overweight |
| Aug-12-19 | Initiated | Piper Jaffray | Overweight |
| Aug-12-19 | Initiated | Wells Fargo | Outperform |
| Aug-12-19 | Initiated | William Blair | Outperform |
| Jul-23-19 | Initiated | Chardan Capital Markets | Buy |
View All
Phreesia Inc Stock (PHR) Latest News
Could Phreesia’s Stock Be Set for a Better Year? Stephens Adds To Best Ideas List - AskTraders.com
How buyback programs support Phreesia Inc stock2025 Trading Recap & AI Forecasted Entry and Exit Points - moha.gov.vn
Aug Update: How MWYN stock reacts to inflationary pressuresVolume Spike & Fast Moving Stock Trade Plans - moha.gov.vn
Aug Update: How supply shortages influence Phreesia Inc stockTrade Exit Report & Expert Verified Stock Movement Alerts - moha.gov.vn
Phreesia, Inc. (NYSE:PHR) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Phreesia, Inc. (NYSE:PHR) Short Interest Down 30.2% in December - MarketBeat
Phreesia Cracks Top 10 as Software Recognition Signals Healthcare AI Momentum - MyChesCo
Capricorn Fund Managers Ltd Takes Position in Phreesia, Inc. $PHR - MarketBeat
Tangible book value per share of Phreesia, Inc. – MUN:19P - TradingView — Track All Markets
Risk On: Will Phreesia Inc stock benefit from M A activityJuly 2025 Short Interest & Fast Moving Trade Plans - moha.gov.vn
Exploring US High Growth Tech Stocks for Potential Expansion - simplywall.st
Phreesia swings to profit as growth accelerates and AccessOne deal lands - MSN
Phreesia Stock Has Been Crushed. We’re Standing By Our Pick. - Barron's
Phreesia (PHR) SVP HR exercises stock options and now holds 162,840 shares - Stock Titan
Phreesia: Profitable At Last, Priced Like It Isn’t (NYSE:PHR) - Seeking Alpha
Phreesia (PHR) price target decreased by 11.76% to 30.42 - MSN
Phreesia (PHR) Price Target Decreased by 11.76% to 30.42 - Nasdaq
Can Phreesia Inc. stock outperform in 2025 bull marketJuly 2025 Summary & Consistent Return Strategy Ideas - Улправда
Can Phreesia Inc. stock deliver consistent EPS growthWeekly Market Report & Consistent Profit Focused Trading Strategies - Улправда
How Phreesia Inc. (19P) stock trades after rate cutsInsider Buying & Technical Pattern Based Signals - Улправда
Phreesia Swings to Profit as Growth Accelerates and AccessOne Deal Lands - MyChesCo
Earnings Report: Can Phreesia Inc. stock outperform in 2025 bull marketJuly 2025 Trends & Weekly Top Performers Watchlists - Улправда
Officer Linetsky Surrenders 94 Of Phreesia Inc [PHR] - TradingView — Track All Markets
Phreesia (PHR) president reports automatic 94-share sale to cover RSU taxes - Stock Titan
Phreesia (NYSE: PHR) officer Evan Roberts boosts holdings via option exercise - Stock Titan
[Form 4] Phreesia, Inc. Insider Trading Activity - Stock Titan
Will Phreesia Inc. stock rally after Fed decisionsJuly 2025 Opening Moves & Weekly Stock Breakout Alerts - Bölüm Sonu Canavarı
Why Phreesia Inc. stock is considered a top pick2025 Performance Recap & Stepwise Trade Signal Implementation - DonanımHaber
Is Phreesia Inc. stock attractive after correctionRate Cut & Weekly Stock Breakout Alerts - DonanımHaber
Phreesia (PHR) analyst model updated to reflect company’s latest financial guidance for 2026-2027 - MSN
Is Phreesia Inc. (19P) stock undervalued at current price2025 Biggest Moves & Low Volatility Stock Recommendations - DonanımHaber
How risky is Phreesia Inc. stock now2025 Support & Resistance & Safe Capital Allocation Plans - Улправда
Is Phreesia Inc. (19P) stock a buy before earnings results2025 EndofYear Setup & Risk Controlled Stock Pick Alerts - Улправда
Phreesia Named to The Software Report’s “Top 50 Software Companies” for the Fourth Consecutive Year - Business Wire
Phreesia executive earns national spotlight on MM+M’s 2025 40 under 40 - MSN
Squarepoint Ops LLC Buys 71,553 Shares of Phreesia, Inc. $PHR - MarketBeat
BMO Capital Sticks to Its Buy Rating for Phreesia (PHR) - The Globe and Mail
AccessOne deal set to lift Phreesia’s payment revenue - S&P Global
PHR (NYSE: PHR) shareholder plans Rule 144 sale of 94 shares - Stock Titan
VP Hui Files To Sell 426 Of Phreesia Inc [PHR] - TradingView — Track All Markets
PHR (PHR) insider plans Rule 144 sale of 426 common shares on NYSE in December 2025 - Stock Titan
Barclays Sticks to Their Buy Rating for Phreesia (PHR) - The Globe and Mail
Piper Sandler sees Doximity and Phreesia as oversold, recommends buying By Investing.com - Investing.com South Africa
Piper Sandler recommends buying Doximity and Phreesia stock after pharma marketing event By Investing.com - Investing.com South Africa
Phreesia (PHR) Receives Updated Price Target from Barclays | PHR Stock News - GuruFocus
Piper Sandler sees Doximity and Phreesia as oversold, recommends buying - Investing.com
Piper Sandler recommends buying Doximity and Phreesia stock after pharma marketing event - Investing.com Australia
Phreesia (PHR) Analyst Model Updated to Reflect Company’s Latest Financial Guidance for 2026-2027 - Insider Monkey
Phreesia Inc Stock (PHR) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):